CURRENT OPINION JOURNAL ALERTS

THOMSON REUTERS ALERTS BRING YOU EACH ISSUE’S TABLE OF CONTENTS

The Current Opinion journals from Thomson Reuters are designed to assist scientists in gathering, digesting and managing the latest scientific thought on pharmaceutical drugs.

Why not sign up below to receive the latest table of contents for our Current Opinion journals delivered direct to your desktop, every issue? Signing up is completely free and without obligation.

*Indicates required field

Which alerts would you like to receive?
  • Current Opinion in Drug Discovery & Development
  • Current Opinion in Investigational Drugs
  • Current Opinion in Molecular Therapeutics
  • IDrugs
Contact Information

What Will We Do With Your Data?

When you submit this form we will send you a confirmation email that includes a link to a Profile Center. You can visit the Profile Center to select your preferences for receiving emails containing product information, newsletters, event invitations and more. You can also opt out of further communications if you choose.

View our privacy policy.

Current Opinion in Drug Discovery & Development


Bimonthly review journal encompassing all chemical aspects of drug R&D, from the initial concept stage, through to process development.

Current Opinion in Investigational Drugs


Monthly publication covering all therapeutic areas, in recognition of the increasingly multi-disciplinary nature of modern drug discovery and development. Current Opinion in Molecular Therapeutics

Current Opinion in Molecular Therapeutics


Bimonthly review on major research developments in molecular medicine

IDrugs


The Investigational Drugs journal brings you reports from the most noteworthy and topical conferences taking place around the world.